How I treat older patients with AML-Reference-Cited by-同舟云学术

How I treat older patients with AML

Published:2000-09-01 Issue:5 Volume:96 Page:1670-1673
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Estey Elihu H.¹

Affiliation:

1. From the Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/96/5/1670/1666835/h8170001670.pdf

Reference36 articles.

1. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission.;Brincker;Cancer Treat Rep.,1985

2. Prognostic factors in cancer clinical trials.;Estey;Clin Cancer Res.,1997

3. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy: a Southwest oncology group study.;Leith;Blood.,1997

4. A randomized placebo-contolled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).;Rowe;Blood.,1995

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML;Neoplasia;2021-03

2. Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome;Annals of Hematology;2020-02-22

4. Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia;International Journal of Laboratory Hematology;2019-04-10

5. Management of acute myeloid leukemia (AML) in elderly and resource constrained setting;Hematology & Transfusion International Journal;2018-05-25